Good tutes (Ra and Redmill) loaded recently - Has catalyst coming up this month and 2H, 2020 - My current avg is 4.77, planning on holding until the end of this year.
$IMGN can be categorized as penny stock because its price per share is below $10
Given this fact this trade idea should be considered risky. But nothing in life that is worthy is free of risk, right?
Since this is a volatile stock I would strongly suggest you should have a proper plan to execute it as a skilled surgeon
In particular, you should set your Stop...
Hi, today we are going to talk about Immunogen and its current landscape.
Immunogen is poised to receive increasing attention from the market after the announcement that it will start new trials based on an FDA advice that a new single-arm study in ovarian cancer could support accelerated approval for Mirvetuximab Soravtansine. We must remember that statistics...
Baby Stock but it's made it down to a trend start so I will attempt to long it and see what happens. if it continues to retrace up then my targets are there.
My graph shows that the stock has a habit to recover to great performance within a period of approx. 200 days (blue squares).
Furthermore I've identified 3 support/resistance lines (black lines).
My guess is that the climb will be kept within the margin of the lower yellow field, were you also can we my prediction (blue lines).
P.S. Pardon me if I'm not down...
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.
IMGN
